SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Shire plc – ‘10-Q’ for 3/31/10 – ‘XML.R13’

On:  Thursday, 5/6/10, at 12:51pm ET   ·   For:  3/31/10   ·   Accession #:  950103-10-1332   ·   File #:  0-29630

Previous ‘10-Q’:  ‘10-Q’ on 11/6/09 for 9/30/09   ·   Next:  ‘10-Q’ on 8/9/10 for 6/30/10   ·   Latest:  ‘10-Q’ on 11/1/18 for 9/30/18

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/06/10  Shire plc                         10-Q        3/31/10   43:4.2M                                   Davis Polk & … LLP 01/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    727K 
 2: EX-10.27    Material Contract                                   HTML    439K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     23K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     23K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     17K 
32: XML         IDEA XML File -- Definitions and References          XML     95K 
38: XML         IDEA XML File -- Filing Summary                      XML     65K 
36: XML.R1      Document And Entity Information                      XML    118K 
37: XML.R2      Unaudited Consolidated Balance Sheets                XML    332K 
19: XML.R3      Unaudited Consolidated Balance Sheets                XML     65K 
                (Parentheticals)                                                 
24: XML.R4      Unaudited Consolidated Balance Sheets                XML     33K 
                (Parentheticals in GBP)                                          
30: XML.R5      Unaudited Consolidated Statements of Income          XML    372K 
29: XML.R6      Unaudited Consolidated Statements of Income          XML     44K 
                (Parentheticals)                                                 
42: XML.R7      Unaudited Consolidated Statement of Changes in       XML    265K 
                Shareholders' Equity                                             
15: XML.R8      Unaudited Consolidated Statements of Comprehensive   XML     97K 
                Income                                                           
28: XML.R9      Unaudited Components of Accumulated Other            XML     58K 
                Comprehensive Income                                             
14: XML.R10     Unaudited Consolidated Statements of Comprehensive   XML     43K 
                Income (Parentheticals)                                          
13: XML.R11     Unaudited Consolidated Statements of Cash Flows      XML    402K 
18: XML.R12     Summary Of Significant Accounting Policies           XML     51K 
34: XML.R13     Business combinations                                XML     38K 
20: XML.R14     Termination costs                                    XML     40K 
21: XML.R15     Reorganization costs                                 XML     60K 
26: XML.R16     Accounts receivable, net                             XML     45K 
43: XML.R17     Inventories                                          XML     43K 
17: XML.R18     Prepaid expenses and other current assets            XML     41K 
12: XML.R19     Investments                                          XML     37K 
23: XML.R20     Other intangible assets, net                         XML     56K 
33: XML.R21     Accounts payable and accrued expenses                XML     45K 
16: XML.R22     Other current liabilities                            XML     40K 
31: XML.R23     Other non-current liabilities                        XML     41K 
22: XML.R24     Commitments and contingencies                        XML     80K 
41: XML.R25     Derivative instruments                               XML     63K 
35: XML.R26     Fair value measurement                               XML     72K 
25: XML.R27     Earnings per share                                   XML     54K 
27: XML.R28     Segmental reporting                                  XML     94K 
39: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    103K 
 6: EX-101.INS  XBRL Instance -- shpgf-20100331                      XML    512K 
 8: EX-101.CAL  XBRL Calculations -- shpgf-20100331_cal              XML    199K 
 9: EX-101.DEF  XBRL Definitions -- shpgf-20100331_def               XML     82K 
10: EX-101.LAB  XBRL Labels -- shpgf-20100331_lab                    XML    822K 
11: EX-101.PRE  XBRL Presentations -- shpgf-20100331_pre             XML    466K 
 7: EX-101.SCH  XBRL Schema -- shpgf-20100331                        XSD     95K 
40: ZIP         XBRL Zipped Folder -- 0000950103-10-001332-xbrl      Zip     79K 


‘XML.R13’   —   Business combinations


This Financial Report is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
<Version> 2.0.0.10 </Version>
<hasSegments> false </hasSegments>
<ReportName> Business combinations </ReportName>
<ReportLongName> 00200 - Disclosure - Business combinations </ReportLongName>
<DisplayLabelColumn> true </DisplayLabelColumn>
<ShowElementNames> false </ShowElementNames>
<RoundingOption/>
<HasEmbeddedReports> false </HasEmbeddedReports>
<Columns>
<Column>
<LabelColumn> false </LabelColumn>
<Id> 1 </Id>
<Labels>
<Label Id="1" Label="3 Months Ended"/>
<Label Id="2" Label="Mar. 31, 2010"/>
</Labels>
<CurrencyCode> usd </CurrencyCode>
<CurrencySymbol> $ </CurrencySymbol>
<FootnoteIndexer/>
<hasSegments> false </hasSegments>
<hasScenarios> false </hasScenarios>
<Segments/>
<Scenarios/>
<Units>
<Unit>
<UnitID> EPS </UnitID>
<UnitType> Divide </UnitType>
<NumeratorMeasure>
<MeasureSchema> http://www.xbrl.org/2003/iso4217 </MeasureSchema>
<MeasureValue> USD </MeasureValue>
<MeasureNamespace> iso4217 </MeasureNamespace>
</NumeratorMeasure>
<DenominatorMeasure>
<MeasureSchema> http://www.xbrl.org/2003/instance </MeasureSchema>
<MeasureValue> shares </MeasureValue>
<MeasureNamespace> xbrli </MeasureNamespace>
</DenominatorMeasure>
<Scale> 0 </Scale>
</Unit>
<Unit>
<UnitID> shares </UnitID>
<UnitType> Standard </UnitType>
<StandardMeasure>
<MeasureSchema> http://www.xbrl.org/2003/instance </MeasureSchema>
<MeasureValue> shares </MeasureValue>
<MeasureNamespace> xbrli </MeasureNamespace>
</StandardMeasure>
<Scale> 0 </Scale>
</Unit>
<Unit>
<UnitID> USD </UnitID>
<UnitType> Standard </UnitType>
<StandardMeasure>
<MeasureSchema> http://www.xbrl.org/2003/iso4217 </MeasureSchema>
<MeasureValue> USD </MeasureValue>
<MeasureNamespace> iso4217 </MeasureNamespace>
</StandardMeasure>
<Scale> 0 </Scale>
</Unit>
</Units>
</Column>
</Columns>
<Rows>
<Row>
<Id> 2 </Id>
<Label> NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS </Label>
<Level> 0 </Level>
<ElementName> shpgf_NotesToTheConsolidatedFinancialStatementsAbstract </ElementName>
<ElementPrefix> shpgf </ElementPrefix>
<IsBaseElement> false </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<ElementDataType> string </ElementDataType>
<ShortDefinition> No definition available. </ShortDefinition>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsSubReportEnd> false </IsSubReportEnd>
<IsCalendarTitle> false </IsCalendarTitle>
<IsTuple> false </IsTuple>
<IsAbstractGroupTitle> true </IsAbstractGroupTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole/>
<IsEPS> false </IsEPS>
<FootnoteIndexer/>
<Cells>
<Cell>
<Id> 1 </Id>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText/>
<NonNumericTextHeader/>
<FootnoteIndexer/>
<hasSegments> false </hasSegments>
<hasScenarios> false </hasScenarios>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<OriginalInstanceReportColumns/>
<ElementDefenition> No definition available. </ElementDefenition>
<IsTotalLabel> false </IsTotalLabel>
</Row>
<Row>
<Id> 3 </Id>
<Label> Business combinations </Label>
<Level> 1 </Level>
<ElementName> us-gaap_BusinessCombinationDisclosureTextBlock </ElementName>
<ElementPrefix> us-gaap </ElementPrefix>
<IsBaseElement> true </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<ElementDataType> string </ElementDataType>
<ShortDefinition> No definition available. </ShortDefinition>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsSubReportEnd> false </IsSubReportEnd>
<IsCalendarTitle> false </IsCalendarTitle>
<IsTuple> false </IsTuple>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole/>
<IsEPS> false </IsEPS>
<FootnoteIndexer/>
<Cells>
<Cell>
<Id> 1 </Id>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Arial;font-size:10pt;font-weight:bold;margin-left:0px;">2</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">.       Business c</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">ombinations</font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Arial;font-size:10pt;margin-left:0px;">On March 31, 2009 the Company acquired the worldwide rights (excluding the </font><font style="font-family:Arial;font-size:10pt;">US</font><font style="font-family:Arial;font-size:10pt;">, </font><font style="font-family:Arial;font-size:10pt;">Canada</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">Barbados</font><font style="font-family:Arial;font-size:10pt;">) to EQUASYM IR and XL for the treatment of </font><font style="font-family:Arial;font-size:10pt;">attention deficit and hyperactivity disorder ("ADHD")</font><font style="font-family:Arial;font-size:10pt;"> from UCB</font><font style="font-family:Arial;font-size:10pt;"> Pharma Limited ("</font><font style="font-family:Arial;font-size:10pt;">UCB</font><font style="font-family:Arial;font-size:10pt;">")</font><font style="font-family:Arial;font-size:10pt;"> for cash consideration of $72.8 million. Included within the recognized purchase price for the acquisition is further consideration of $18.2 million, which may become payable in 2010</font><font style="font-family:Arial;font-size:10pt;"> and 2011</font><font style="font-family:Arial;font-size:10pt;"> if certain </font><font style="font-family:Arial;font-size:10pt;">sales</font><font style="font-family:Arial;font-size:10pt;"> targets are met. This acquisition broaden</font><font style="font-family:Arial;font-size:10pt;">ed</font><font style="font-family:Arial;font-size:10pt;"> the scope of Shire's ADHD portfolio and facilitate</font><font style="font-family:Arial;font-size:10pt;">d</font><font style="font-family:Arial;font-size:10pt;"> immediate access to the European ADHD market as well as provid</font><font style="font-family:Arial;font-size:10pt;">ing</font><font style="font-family:Arial;font-size:10pt;"> Shire the opportunity to enter additional markets</font><font style="font-family:Arial;font-size:10pt;"> around the </font><font style="font-family:Arial;font-size:10pt;">world.</font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Arial;font-size:10pt;margin-left:0px;">The acquisition of EQUASYM IR and XL </font><font style="font-family:Arial;font-size:10pt;">was </font><font style="font-family:Arial;font-size:10pt;">accounted for as a business combination. The purchase price </font><font style="font-family:Arial;font-size:10pt;">was</font><font style="font-family:Arial;font-size:10pt;"> allocated to the currently marketed products acquired ($73.0 million), IPR&D ($5.5 million), other liabilities ($0.7 million) </font><font style="font-family:Arial;font-size:10pt;">and goodwill ($13.2 million).</font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p>
</NonNumbericText>
<NonNumericTextHeader> 2.       Business combinations On March 31, 2009 the Company acquired the worldwide rights (excluding the US, Canada </NonNumericTextHeader>
<FootnoteIndexer/>
<hasSegments> false </hasSegments>
<hasScenarios> false </hasScenarios>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<OriginalInstanceReportColumns/>
<ElementDefenition> Description of a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. This element may be used as a single block of text to encapsulate the entire disclosure (including data and tables) regarding business combinations, including leverage buyout transactions (as applicable). </ElementDefenition>
<ElementReferences> Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141 -Paragraph 51, 52 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 88-16 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141R -Paragraph 67-73 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141R -Paragraph F4 -Subparagraph e -Appendix F </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
</Row>
</Rows>
<Footnotes/>
<ComparabilityReport> false </ComparabilityReport>
<NumberOfCols> 1 </NumberOfCols>
<NumberOfRows> 2 </NumberOfRows>
<HasScenarios> false </HasScenarios>
<MonetaryRoundingLevel> UnKnown </MonetaryRoundingLevel>
<SharesRoundingLevel> UnKnown </SharesRoundingLevel>
<PerShareRoundingLevel> UnKnown </PerShareRoundingLevel>
<HasPureData> false </HasPureData>
<SharesShouldBeRounded> true </SharesShouldBeRounded>
</InstanceReport>

Top
Filing Submission 0000950103-10-001332   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 11:08:06.2am ET